Singapore markets open in 3 hours 49 minutes

Eupraxia Pharmaceuticals Inc (EPRX-WT.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
0.27000.0000 (0.00%)
At close: 11:21AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-30,368
-28,221
-18,490
-22,990
-3,997
-
Depreciation & amortisation
155.489
155.527
147.894
111.529
116.809
-
Stock-based compensation
1,308
1,412
1,434
4,215
228.68
-
Change in working capital
7,021
5,352
1,515
-211.431
1,583
-
Accounts receivable
-
-
-
-
-
135.271
Accounts payable
-
577.908
1,324
-
-
-
Other working capital
-22,309
-20,757
-14,631
-15,073
-403.784
-
Other non-cash items
588.661
586.004
659.951
3,409
1,797
-
Net cash provided by operating activities
-22,237
-20,684
-14,395
-14,642
-403.784
-
Cash flows from investing activities
Investments in property, plant and equipment
-72.098
-73.377
-235.55
-431.673
-
-9.479
Purchases of investments
-
0
-3,272
-9,000
-
-
Sales/maturities of investments
-
0
13,342
0
-
-
Other investing activities
-
-
-
-5,018
-56.687
-1,886
Net cash used for investing activities
-72.098
-73.377
9,834
-14,450
24.618
-
Cash flows from financing activities
Debt repayment
-145.633
-144.437
-142.268
-586.426
-1,101
-
Common stock issued
38,740
15,887
10,637
37,833
0
-
Other financing activities
-
-
-
-
-235.949
-
Net cash used provided by (used for) financing activities
43,973
21,014
10,801
49,915
-626.644
-
Net change in cash
21,664
256.97
6,240
20,824
-1,006
-
Cash at beginning of period
13,928
18,263
12,531
150.126
1,156
-
Cash at end of period
35,592
19,342
18,263
20,892
150.126
-
Free cash flow
Operating cash flow
-22,237
-20,684
-14,395
-14,642
-403.784
-
Capital expenditure
-72.098
-73.377
-235.55
-431.673
-
-9.479
Free cash flow
-22,309
-20,757
-14,631
-15,073
-403.784
-